Company Filing History:
2 out of 8,396 
2 out of 2,971 
1 out of 444 
Years Active: 2015-2025
Title: Mary Lynn Baniecki: Innovator in Pathogen Detection and Malaria Treatment
Introduction
Mary Lynn Baniecki is a distinguished inventor based in Cambridge, MA (US). She has made significant contributions to the fields of pathogen detection and malaria treatment, holding a total of 2 patents. Her innovative work has the potential to impact public health and disease management.
Latest Patents
Baniecki's latest patents include groundbreaking inventions. The first patent is titled "Nucleic acid amplification assays for detection of pathogens." This invention relates to a method for generating primers and/or probes for analyzing samples that may contain pathogen target sequences. The process involves providing a set of input genomic sequences to one or more target pathogens, generating target sequences, identifying highly conserved target sequences, and creating primers or probes based on these sequences.
The second patent is focused on "2-aminoindole compounds and methods for the treatment of malaria." This invention outlines methods for treating subjects with malaria by administering a 2-aminoindole compound represented by a specific formula. The detailed values and preferred variables of the compound are defined within the patent.
Career Highlights
Mary Lynn Baniecki has worked with prestigious institutions such as the Massachusetts Institute of Technology and Harvard College. Her experience in these renowned organizations has allowed her to collaborate with leading experts in her field and contribute to significant advancements in medical research.
Collaborations
Throughout her career, Baniecki has collaborated with notable individuals, including Hayden Metsky and Pardis Sabeti. These partnerships have fostered innovation and have been instrumental in her research endeavors.
Conclusion
Mary Lynn Baniecki is a remarkable inventor whose work in pathogen detection and malaria treatment showcases her dedication to improving public health. Her patents reflect her innovative spirit and commitment to scientific advancement.